MERCK SHARP & AMP DOHME CORP has a total of 16 patent applications. Its first patent ever was published in 2009. It filed its patents most often in Republic of Korea and Taiwan. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are ASUBIO PHARMA CO LTD, IBFB GMBH PRIVATES INST FUER B and AVENTIS FARMA DOJCHLAND GMBKH.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 9 | |
#2 | Taiwan | 7 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Microorganisms | |
#5 | Peptides | |
#6 | Fermentation | |
#7 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Strapps Walter | 3 |
#2 | Pickering Victoria | 3 |
#3 | Wu Hao | 2 |
#4 | Soll Richard | 2 |
#5 | Winter Christopher | 2 |
#6 | Sathyanarayanan Sriram | 2 |
#7 | Parmee Emma R | 2 |
#8 | Shah Jyoti | 2 |
#9 | Koch Uwe | 1 |
#10 | Li Hong | 1 |
Publication | Filing date | Title |
---|---|---|
TW201136919A | Inhibitors of hepatitis C virus NS5B polymerase | |
TW201136603A | 15-valent pneumococcal polysaccharide-protein conjugate vaccine composition | |
KR20110107395A | Indole derivatives as crth2 receptor antagonists |